AU Patent

AU2017312970B2 — 2-oxo-imidazopyridines as reversible BTK inhibitors and uses thereof

Assigned to Merck Patent GmbH · Expires 2021-08-12 · 5y expired

What this patent protects

The present invention relates to imidazo pyridine compounds, and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.

USPTO Abstract

The present invention relates to imidazo pyridine compounds, and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.

Drugs covered by this patent

Patent Metadata

Patent number: AU2017312970B2
Jurisdiction: AU
Classification: —
Expires: 2021-08-12
Drug substance claim: No
Drug product claim: No
Assignee: Merck Patent GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.